Literature DB >> 12813368

Cepharanthin, an alkaloid from Stephania cepharantha, inhibits increased pulmonary vascular permeability in an ovine model of sepsis.

Kazunori Murakami1, Robert A Cox, Hal K Hawkins, Frank C Schmalstieg, Roy W McGuire, Jeffrey M Jodoin, Lillian D Traber, Daniel L Traber.   

Abstract

Sepsis is a life-threatening event when it occurs in patients suffering from smoke inhalation injury. Pneumonia is one of the most frequent sources of infection in sepsis. Activated leukocytes likely play a role in the pathogenesis of sepsis. Cepharanthin is a biscoclaurine alkaloid that reportedly inhibits the activation of neutrophils. In this study, we investigated the effects of cephranthin on a post-smoke inhalation model of sepsis in sheep. Female sheep (n = 15) were surgically prepared for the study. After 5 days recovery from the operative procedures, tracheostomy was performed in all animals and 48 breaths of cotton smoke (<40 degrees C) were given via a modified bee smoker under halothane anesthesia. After smoke insufflation, Pseudomonas aeruginosa (5 x 109 cfu/kg) was instilled into the airway using a bronchoscope. All of the animals were mechanically ventilated with 100% O(2). Cepharanthin (1.3 mg/kg/h) was infused in five sheep continuously beginning 1 h after the insult and thereafter for the remainder of the 24-h study period. Control animals (n = 6) were treated with 5% dextrose as a vehicle control. Cepharanthin significantly attenuated changes in lung histology as well as in lung wet/dry weight ratio. An in vitro study revealed that cepharanthin inhibited the release of neutrophil elastase from isolated neutrophils stimulated with either formyl-methyl-leucyl-phenylalanine (fMLP) or phorbol myristate acetate with an IC(50) of 60 microM. Cepharanthin also inhibited the fMLP-induced increase in intracellular calcium levels of neutrophils. This result indicates cepharanthin inhibits protein kinase C or a more downstream signaling pathway in neutrophil activation. In conclusion, cepharanthin attenuates acute lung injury and septic shock after smoke inhalation in sheep.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813368     DOI: 10.1097/01.shk.0000065768.72937.62

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells.

Authors:  Zan Chen; Chen Huang; Yan-ling Yang; Yi Ding; Han-qiang Ou-Yang; You-yi Zhang; Ming Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

Review 2.  Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication.

Authors:  Chain-Fa Su; Shang Jyh Kao; Hsing I Chen
Journal:  World J Crit Care Med       Date:  2012-04-04

3.  Effects of phorbol myristate acetate and sivelestat on the lung injury caused by fat embolism in isolated lungs.

Authors:  Chia-Chih Lin; Pei-Hsin Liu; Shang Jyh Kao; Hsing I Chen
Journal:  J Biomed Sci       Date:  2012-01-05       Impact factor: 8.410

4.  Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations.

Authors:  Hsing I Chen
Journal:  J Geriatr Cardiol       Date:  2011-03       Impact factor: 3.327

Review 5.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

6.  Salutary Effects of Cepharanthine against Skeletal Muscle and Kidney Injuries following Limb Ischemia/Reperfusion.

Authors:  Ming-Chang Kao; Chih-Yang Chung; Ya-Ying Chang; Chih-Kung Lin; Joen-Rong Sheu; Chun-Jen Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.